BIB

ETFNASDAQ 已收盘

ProShares Ultra Nasdaq Biotechnology

51.16 USD
▼-1.94-3.65%
盘后 51.00 -0.32%
2026-11-20
市值
—
规模 AUM
$96.74M
EPS
—
股息率
0.22%
52 周区间
36.89 – 63.20
成交量
41.99K
Beta
1.24
目标价
—
52W 低 36.8952W 高 63.20
价格走势

公司简介

The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. BIB was launched on Apr 8, 2010 and is issued by ProShares.